
ErasmusMC.Urology.Research
@emcurolresearch
Updates, publications and news from the Erasmus MC Urology Research Department
ID: 1273544763682234368
18-06-2020 09:15:56
32 Tweet
46 Followers
77 Following

NPEPPS key to cisplatin resistance in bladder cancer?! Dan Theodorescu @mpscholtes Tahlita Zuiverloon MD PhD Teemu Daniel Laajala Ashish M. Kamat, MD, MBBS Peter Black @joostboormans Lars Dyrskjøt Dr. Bishoy M. Faltas IBCN Bart Kiemeney European Urology @noahhan Tom Powles David McConkey BCAN NCT Chapter biorxiv.org/content/10.110…

Great work from Christiaan de Jong Tahlita Zuiverloon MD PhD @joostboormans Joep J. de Jong Ellen Zwarthoff and Robert Hoedemaeker Blaaskankercentrum Franciscus Amphia Ziekenhuis


Een geweldige Q&A over prostaatkanker van Professor Bangma chris bangma anserprostaatcentrum.nl/nieuws/tweehon…


Great work on exosomes by our cancer scientists! chris bangma Blaaskankercentrum European Association of Urology (EAU) @joostboormans Tahlita Zuiverloon MD PhD Guido Jenster


Congratulations @bertilblok ! Blaaskankercentrum chris bangma Erasmus MC European Association of Urology (EAU) amazingerasmusmc.nl/actueel/miljoe…

Upcoming weekend is exciting, as the #EAU21 will take place! As a group, we have several interesting presentations and abstracts accepted. Want to know when? See: erasmusurologyresearch.nl Blaaskankercentrum European Association of Urology (EAU) @joostboormans Ellen Zwarthoff Joep J. de Jong Christiaan de Jong chris bangma

Delighted to share our research letter to European Urology European Urology (IF 20) highlighting our recent position paper in @ISEV_JEV (IF 21) on the need of rigor and standardization in #extracellular_vesicle research! ErasmusMC.Urology.Research @IsevComms WebEVTalk authors.elsevier.com/a/1dsjM14kplnV…

The prediction of biochemical recurrence after radical prostatectomy can be improved with detailed pathology. Read more about our latest research here: sciencedirect.com/science/articl… Monique Roobol @joostboormans chris bangma Guido Jenster

Great work from our international collaboration: Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical BCG medrxiv.org/content/10.110… Christiaan de Jong Dan Theodorescu Tahlita Zuiverloon MD PhD @joostboormans Emiel Janssen Ellen Zwarthoff Teemu Daniel Laajala

The IMPASSE study amazingerasmusmc.nl/urologie/erasm… will investigate if our previously developed BCG Response Subtypes medrxiv.org/content/10.110… can be prospectively validated, and determines if targeted therapies using PDx tumoroid models are feasible. Blaaskankercentrum Tahlita Zuiverloon MD PhD Christiaan de Jong

With a relatively simple test, urologist may accurately determine in the future which patients will benefit from BCG bladder instillations. In 30/50% percent of patients, treatment is not successful, while treatment duration is lengthy and unpleaseant. amazingerasmusmc.com/oncology/pcr-t…



